SRPT - SAREPTA THERAPEUTICS INC
This page shows which of the focused investors we track hold SRPT and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2025 it was held by 1 manager with an aggregate reported value of $30.82M, which is 0.00% of the combined portfolio.
As of Q3 2025, 1 tracked institutional manager held SRPT (SAREPTA THERAPEUTICS INC) with an aggregate reported value of $30.82M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades SRPT — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2025
- Ticker
- SRPT
13F data is delayed and excludes shorts/non-13F assets.
Holders
Other instruments
Bonds, warrants, or other non-share-class principal positions in SRPT.
| 1 | Howard Marks - Oaktree Capital Management | Add +610.0% | 34,930,000 | $30.82M |
Loading holder history for SRPT…